The Science of Teratology in a Regulatory Setting

  • Neil Chernoff
Part of the Basic Life Sciences book series


The science of teratology is discussed from a regulatory point of view. A brief history of this branch of toxicology is presented with emphasis on specific instances of the inadvertent production of birth defects in humans as a result of exposure to exogenous agents. The basic principles of teratology are elucidated as a means of understanding current test protocols and their scientific rationale. A typical, general protocol is given and some of the major shortcomings of such a bioassay are presented. Among these shortcomings are the problems of significance of fetal toxicity and lack of a postnatal component to the teratology test system. The teratogenic and/ or fetotoxic potential of selected pesticides are examined with special reference to the bioassay problems alluded to. Pesticides discussed include cacodylic acid, endrin, benomyl, ETU, nitrofen, and mirex. Finally, a brief discussion of a proposed teratology screen using pregnant laboratory animals is presented.


Dose Level Oral Gavage Fetal Alcohol Syndrome Fetal Weight Developmental Toxicity 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Barrach, H., and Neubert, D., 1980, Significance of organ culture techniques for evaluation of prenatal toxicity, Arch. Toxicol., 45:161–187.PubMedCrossRefGoogle Scholar
  2. Canadian Health and Welfare, 1973, “The Testing of Chemicals for Carcinogenicity, Mutagenicity, and Teratogenicity,” Ministry of Health and Welfare, Canada.Google Scholar
  3. Chernoff, N., and Kavlock, R. J., 1982, A potential in vivo screen for the determination of adverse perinatal effects, J. Toxicol. Environ. Health, 10:541–550.PubMedCrossRefGoogle Scholar
  4. Chernoff, N., Kavlock, R. J., Hanisch, R. C., Whitehouse, D. A., Gray, J. A., and Gray, L. E., Jr., 1979a, Perinatal toxicity of endrin in rodents, I, Fetotoxic effects of prenatal exposure in hamsters, Toxicol., 13:155–165.Google Scholar
  5. Chernoff, N., Kavlock, R. J., Rogers, E. H., Carver, B. D., and Murray, S., 1979b, Perinatal toxicity of maneb, ethylethio-urea, and ethylenebisisothiocyanate sulfide in rodents, J. Toxicol. Environ. Health, 5:821–834.PubMedCrossRefGoogle Scholar
  6. Chernoff, N., Linder, R. E., Scotti, T. M., Rogers, E. L., Carver, B. D., and Kavlock, R. J., 1979c, Fetotoxicity and cataracto genicity of mirex in rats and mice with notes of kepone, Environ. Res., 18:257–269.PubMedCrossRefGoogle Scholar
  7. Chernoff, N., Stevens, J. T., and Rogers, E. H., 1979d, Perinatal toxicology of mirex administered in the diet. I. Viability, growth, oataractogenicity and tissue levels, Toxicol. Lett., 4:263–268.CrossRefGoogle Scholar
  8. Environmental Protection Agency, 1978, “The Federal Insecticide, Fungicide, and Rodenticide Act as Amended,” U.S. Government Printing Office, 287-044/6025, Washington, D.C.Google Scholar
  9. Environmental Protection Agency, 1982, “Guidelines for Testing,” Section 83-3 of Subpart F, National Toxicological Information Service, Washington, D.C.Google Scholar
  10. Evans, H. E., and Sack, W. D., 1973, Prenatal development of domestic and laboratory mammals: Growth curves, external features and selected references, Anat. Histol. Embryol., 2:11–45.CrossRefGoogle Scholar
  11. Gaylor, D. W., 1978, Methods and concepts of biometrics applied to teratology, in: “Handbook of Teratology,” J. G. Wilson and F. C. Fraser, eds., Vol. 4, Plenum Press, New York, pp. 429–444.Google Scholar
  12. Gray, L. E., Jr., Kavlock, R. J., Chernoff, N., McLamb, J., and Gray, J., 1981, Perinatal toxicity of endrin in rodents. III. Effects on the behavior of offspring of hamsters and rats receiving perinatal exposure, Toxicology, 21:187–202.PubMedCrossRefGoogle Scholar
  13. Gray, L. E., Jr., Kavlock, R. J., Chernoff, N., Ferrel, J., McLamb, J., and Ostby, J., 1982, Prenatal exposure to the herbicide TOK destroys the rodent Harderian gland, Science, 215:293–294.PubMedCrossRefGoogle Scholar
  14. Greene, R. R., Burill, M. W., and Ivy, A. C., 1939, Experimental intersexuality: The effect of antenatal androgens on sexual development of female rats, Amer. J. Anat., 65:415–469.CrossRefGoogle Scholar
  15. Gregg, N. M., 1941, Congenital cataract following German measles in the mother, Trans, Ophthalmol. Soc. Aust., 3:35–46.Google Scholar
  16. Gudernatsch, J. F., and Bagg, H. J., 1920, Disturbances in the development of mammalian embryos caused by radium emanation, Proc. Soc. Exp. Biol. Med., 17:183–187.Google Scholar
  17. Hale, F., 1935, The relation of vitamin A to anophthalmos in pigs, Amer. J. Ophthalmol., 18:1087.Google Scholar
  18. Hanshaw, J. B., 1970, Developmental abnormalities associated with congenital cytomegalovirus infection, Advan. Teratol., 4:64–93.Google Scholar
  19. Haseman, J. K., and Hogan, M. D., 1975, Selection of the experimental unit in teratology studies, Teratology, 12:165–172.PubMedCrossRefGoogle Scholar
  20. Haseman, J. K., and Kupper, L. L., 1979, Analysis of dichotolmous response data from certain toxicological experiments, Biometrics, 35:281–293.PubMedCrossRefGoogle Scholar
  21. Herbst, A. L., Ulfelder, H., and Poskanzer, D. C., 1971, Adenocarcinoma of the vagina: Association of maternal stilbestrol therapy with tumor appearance in young women, N. Engl. J. Med., 284:878–881.PubMedCrossRefGoogle Scholar
  22. Jones, K. L., and Smith, D. W., 1973, Recognition of the fetal alcohol syndrome in early infancy, Lancet, 2:999–1001.CrossRefGoogle Scholar
  23. Kavlock, R. J., and Gray, J. A., 1982, Morphological, biochemical and physiological assessment of perinatally-induced renal dysfunction, J. Toxicol. Environ. Health, 10:541–550.PubMedCrossRefGoogle Scholar
  24. Kavlock, R. H., Chernoff, N., Hanisch, R.C., Gray, J. A., Rogers, E., and Gray, L. E., Jr., 1981, Perinatal toxicity of endrin in rodents. II. Fetotoxic effects of prenatal exposure in rats and mice, Toxicology, 21:141–150.PubMedCrossRefGoogle Scholar
  25. Kavlock, R. J., Chernoff, N., Gray, L. E., Jr., and Whitehouse, D., 1982a, Teratogenic effects of benomyl in rodents, with special emphasis on the route of administration, Toxicol. Appl. Pharmacol., 62:44–54.PubMedCrossRefGoogle Scholar
  26. Kavlock, R. J., Chernoff, N., Rogers, E., Whitehouse, D., Carver, B., Gray, J., and Robinson, K., 1982b, An analysis of feto-toxicity using biochemical endpoints of organ differentiation, Teratology, 26:183–194.PubMedCrossRefGoogle Scholar
  27. Lenz, W., 1961, Kindliche missbildungen nach medikament wahrend der draviditat? Deutsch. Med. Wochenschr., 86:2555–2556.Google Scholar
  28. Matsumoto, H. G., Croyo, K., and Takevchi, T., 1965, Fetal Minimata disease: A neuropathological study of two cases of intra-uterine intoxication by a methylmercury compound, J. Neuropathol. Exp. Neurol., 24:563–574.PubMedCrossRefGoogle Scholar
  29. McBride, W. G., 1961, Thalidomide and congenital abnormalities, Lancet, 2:1358.CrossRefGoogle Scholar
  30. McLachlan, J. A., Newbold, R. R., Korach, K. S., Lamb, J. C., IV, and Suzuki, Y., 1981, Transplacental toxicology: Prenatal factors influencing postnatal fertility, in: “Developmental Toxicology,” C. A. Kimmel and J. Buelke-Sam, eds., Raven Press, New York, pp. 213–232.Google Scholar
  31. OECD “Guidelines for Testing of Chemicals, #x201D; 1982, Section 414, Organization of Economic Cooperation and Development, Paris, France.Google Scholar
  32. Ottolenghi, A. D., Haseman, J. K., and Suggs, F., 1974, Teratogenic effects of aldrin, dieldrin, and endrin in hamsters and mice, Teratology, 9:11–16.PubMedCrossRefGoogle Scholar
  33. Roberts, D. W., Chapman, J. R., 1981, Concepts essential to the assessment of toxicity in the developing immune system, in: “Developmental Toxicology,” C. A. Kimmel and J. Buelke-Sam, eds., Raven Press, New York, pp. 167–189.Google Scholar
  34. Rodier, P., 1978, Postnatal functional evaluations, in: “Handbook of Teratology,” J. G. Wilson and F. C. Fraser, eds., Vol. 4, Plenum Press, New York, pp. 397–428.Google Scholar
  35. Rogers, E. H., Chernoff, N., and Kavlock, R. J., 1981, The teratogenic potential of cacadylic acid in the rat and mouse, Drug Chem. Toxicol., 4:49–61.PubMedCrossRefGoogle Scholar
  36. Schwetz, B. A., 1980, Monitoring problems in teratology, in: “Scientific Considerations in Monitoring and Evaluating Toxicological Research,” E. J. Gralla, ed., Hemisphere Publishing, New York, pp. 179–182.Google Scholar
  37. Shepard, T. H., 1980, “Catalog of Teratogenic Agents,” Third Edition, Johns Hopkins University Press, Baltimore, Maryland.Google Scholar
  38. Sternberg, S. S., 1979, The carcinogenesis, mutagenesis and terato-genesis of insecticides. Review of studies in animals and man. Pharmac. Ther., 6:147–166.CrossRefGoogle Scholar
  39. Sullivan, F. M., and Barlow, S. M., 1979, Congenital malformations and other reproductive hazards from environmental chemicals, Proc. Roy. Soc. Lond. B., 205:92–110.CrossRefGoogle Scholar
  40. Thiersch, J. B., 1952, Therapeutic abortions with a folic acid antagonist, 4-aminopteroylglutamic acid (4-amino PGA), administered by the oral route, Amer. J. Obstet. Gynecol., 63:1298–1304.Google Scholar
  41. Warkany, J., 1977, History of teratology, in: “Handbook of Teratology,” J. G. Wilson and F. C. Fraser, eds., Vol. 1, Plenum Press, New York, pp. 3–45.Google Scholar
  42. Wilkins, L., 1960, Masculinization of female fetus due to use of orally given progestins, J. Amer. Med. Assoc., 172:1028–1032.CrossRefGoogle Scholar
  43. Wilson, J. G., 1973, “Environment and Birth Defects,” Academic Press, New York, 305 pages.Google Scholar
  44. Wilson, J. G., 1977a, Current status of teratology — General principles and mechanisms derived from animal studies, in: “Handbook of Teratology,” J. G. Wilson and F. C. Fraser, eds., Vol. 1, Plenum Press, New York, pp. 47–74.Google Scholar
  45. Wilson, J. G., 1977b, Environmental chemicals, in: “Handbook of Teratology,” J. G. Wilson and F. C. Fraser, eds., Vol. 1, Plenum Press, New York, pp. 357–386.Google Scholar
  46. Wilson, J. G., 1978, Review of in vitro systems with potential for use in teratogenicity screening, J. Env. Path. Toxicol., 2:149–167.Google Scholar
  47. Woo, D. C., and Hoar, R. M., 1972, “Apparent hydronephrosis” as a normal aspect of renal development in late gestation of rats: The effect of methyl salicylate, Teratology, 6:191–196.PubMedCrossRefGoogle Scholar
  48. World Health Organization, 1967, Principles for the testing of drugs for teratogenicity, WHO Technical Report, Series No. 364, Geneva, Switzerland.Google Scholar

Copyright information

© Plenum Press, New York 1985

Authors and Affiliations

  • Neil Chernoff
    • 1
  1. 1.Health Effects Research Laboratory, Developmental Biology DivisionU.S. Environmental Protection AgencyResearch Triangle ParkUSA

Personalised recommendations